semaglutide for obesity A new era': How could change the treatment landscape Adults receiving semaglutide as their

Short-term administration of the GLP-1 analog liraglutide decreases circulating leptin and increases GIP levels and these changes are associated with alterations in CNS responses to food cues: A randomized, placebo-controlled, crossover study

GLP-1 Is Driving Discovery Across Channels

The primary endpoint was the presence of increased RCG, defined as, the presence of solids, thick liquids, or more than 1.5 mL/kg of clear liquids on gastric ultrasonography. Among the 124 subjects (median age, 56 years, 60% female), the prevalence of increased RGC was 56% (35 of 62) in subjects with GLP-1 RA use compared with 19% (12 of 62) in subjects not taking a GLP-1 RA drug

doi:10.1002/dmrr.70058 Tang B, Sjlander A, Wastesson JW, et al

Current medical research (20242026) evaluating cellular therapies for spinal cord injuries and severe neuropathies universally requires patients to have optimal B12 levels

Gut & Anti-Inflammatory Support Protects and repairs the gastrointestinal lining